This company has been acquired
Science 37 Holdings 配当金
配当金 基準チェック /06
Science 37 Holdings does not have a record of paying a dividend.
主要情報
n/a
配当利回り
0.6%
バイバック利回り
| 総株主利回り | 0.6% |
| 将来の配当利回り | n/a |
| 配当成長 | n/a |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 配当性向 | n/a |
最近の配当金アップデート
更新なし
Recent updates
Science 37 Holdings, Inc. (NASDAQ:SNCE) Might Not Be As Mispriced As It Looks
Dec 18
Investors Continue Waiting On Sidelines For Science 37 Holdings, Inc. (NASDAQ:SNCE)
Apr 17Science 37, Syapse team for faster patient enrollment in cancer trials
Aug 18Science 37 reports Q2 mixed earnings; narrows FY22 guidance
Aug 11Results: Science 37 Holdings, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
May 13Science 37 Holdings (NASDAQ:SNCE) Is In A Good Position To Deliver On Growth Plans
Apr 11Science 37: Pioneering Decentralized Clinical Trials
Jan 02We Think Science 37 Holdings (NASDAQ:SNCE) Can Afford To Drive Business Growth
Nov 04決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if SNCE's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if SNCE's dividend payments have been increasing.
配当利回り対市場
| Science 37 Holdings 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (SNCE) | n/a |
| 市場下位25% (US) | 1.5% |
| 市場トップ25% (US) | 4.5% |
| 業界平均 (Life Sciences) | 0.5% |
| アナリスト予想 (SNCE) (最長3年) | n/a |
注目すべき配当: Unable to evaluate SNCE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate SNCE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate SNCE's payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as SNCE has not reported any payouts.